SHS acquires Spiegelberg

The investor was attracted to the company as Spiegelberg is a medical technology specialist in the fields of intracranial pressure monitoring as well as antibacterial technologies.

The parties agreed on a payment plan over an extended period of time, meaning the vendors will still receive a share of the company's profits over the course of the plan. The investment was made from the €70m SHS Fonds III.

Company
Spiegelberg is based in Hamburg and develops, produces and distributes specialised catheters and probes for neurosurgical use in the brain as well as antimicrobial products to prevent infections acquired in hospital. The products are used for monitoring intracranial pressure and external ventricular drainage. In 2010, the company had a turnover of €2.5m and is looking to increase this to €3m in 2011. Established in 1986, Spiegelberg currently employs 30 people.

People
Bernhard Schirmers is founder and partner at SHS.

Advisers
Shareholders – Livingstone Partners (Corporate finance).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH
• Healthcare
• Expansion
• Germany